BSE Live
Jul 31, 16:01Prev. Close
5.10
Open Price
5.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jul 31, 15:40Prev. Close
4.95
Open Price
5.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Vivimed Labs (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -3.85 | -5.48 | -39.62 | -8.16 | -8.67 | |
| Diluted EPS (Rs.) | -3.74 | -5.32 | -39.62 | -7.92 | -8.42 | |
| Cash EPS (Rs.) | -1.42 | -3.08 | -26.55 | -5.95 | -1.98 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | -8.82 | -5.24 | 0.17 | 39.35 | 47.47 | |
| Book Value [InclRevalReserve]/Share (Rs.) | -4.24 | -0.66 | 4.75 | 43.93 | 52.05 | |
| Revenue from Operations/Share (Rs.) | 14.02 | 17.98 | 22.57 | 28.62 | 103.90 | |
| PBDIT/Share (Rs.) | -1.05 | -2.13 | -22.47 | -0.82 | 4.77 | |
| PBIT/Share (Rs.) | -3.49 | -4.53 | -35.55 | -3.02 | -1.93 | |
| PBT/Share (Rs.) | -3.84 | -4.82 | -39.88 | -7.82 | -8.43 | |
| Net Profit/Share (Rs.) | -3.85 | -5.48 | -39.62 | -8.16 | -8.67 | |
| NP After MI And SOA / Share (Rs.) | -3.85 | -5.48 | -39.62 | -8.16 | -8.67 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | -7.46 | -11.82 | -99.59 | -2.86 | 4.58 | |
| PBIT Margin (%) | -24.85 | -25.19 | -157.53 | -10.56 | -1.85 | |
| PBT Margin (%) | -27.39 | -26.82 | -176.72 | -27.32 | -8.10 | |
| Net Profit Margin (%) | -27.48 | -30.48 | -175.59 | -28.50 | -8.34 | |
| NP After MI And SOA Margin (%) | -27.48 | -30.48 | -175.59 | -28.50 | -8.34 | |
| Return on Networth/Equity (%) | 0.00 | 0.00 | -23,087.35 | -20.73 | -18.26 | |
| Return on Capital Employed (%) | -5.63 | -6.94 | -52.25 | -2.80 | -1.68 | |
| Return on Assets (%) | -3.47 | -4.77 | -33.24 | -5.34 | -5.57 | |
| Total Debt/Equity (X) | -5.14 | -8.67 | 266.03 | 1.10 | 0.64 | |
| Asset Turnover Ratio (%) | 0.12 | 0.15 | 0.17 | 0.18 | 0.13 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.80 | 0.83 | 0.78 | 1.36 | 1.55 | |
| Quick Ratio (X) | 0.66 | 0.68 | 0.60 | 0.71 | 0.80 | |
| Inventory Turnover Ratio (X) | 1.89 | 1.25 | 1.17 | 0.58 | 0.25 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | -2.94 | -7.25 | -5.19 | -0.17 | 0.73 | |
| Interest Coverage Ratios (Post Tax) (%) | -2.94 | -7.25 | -5.19 | -0.17 | 0.73 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 0.00 | 0.00 | 430.11 | 471.51 | 378.03 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 2.30 | 1.99 | 0.44 | |
| EV/EBITDA (X) | 0.00 | 0.00 | -2.31 | -69.44 | 9.57 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.30 | 0.50 | 0.15 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.00 | 0.00 | 38.87 | 0.37 | 0.33 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.30 | 0.50 | 0.15 | |
| Earnings Yield | 0.00 | 0.00 | -5.94 | -0.56 | -0.55 |
14.11.2025
Vivimed Labs Consolidated September 2025 Net Sales at Rs 20.61 crore, down 16.79% Y-o-Y
14.11.2025
Vivimed Labs Standalone September 2025 Net Sales at Rs 18.66 crore, down 15.8% Y-o-Y
24.06.2025
Vivimed Labs Standalone March 2025 Net Sales at Rs 22.58 crore, down 37.95% Y-o-Y
03.06.2025
Vivimed Labs Consolidated March 2025 Net Sales at Rs 25.61 crore, down 33.67% Y-o-Y
14.11.2025
Vivimed Labs Consolidated September 2025 Net Sales at Rs 20.61 crore, down 16.79% Y-o-Y
14.11.2025
Vivimed Labs Standalone September 2025 Net Sales at Rs 18.66 crore, down 15.8% Y-o-Y
24.06.2025
Vivimed Labs Standalone March 2025 Net Sales at Rs 22.58 crore, down 37.95% Y-o-Y
03.06.2025
Vivimed Labs Consolidated March 2025 Net Sales at Rs 25.61 crore, down 33.67% Y-o-Y